Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
49 pending office actions • 39 art units • 49 examiners • 0 of 49 (0%) have an AI response strategy ready • 37 patents granted in the last 365 days
University of Utah Research Foundation has 48 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 48 examiners across 38 art units, showing complete examiner dispersion and a broader but recurring art-unit footprint.
ROY, BAISAKHI is the busiest examiner, with 1 pending matter. Examiner-specific concentration is absent in the available data, so portfolio value is likely to come from disciplined matter tracking, technology coordination, and consistent support for complex disclosures.
Based on the USPTO statutory response window for each pending office action. 16 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 16 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (2%) |
| §101 + other | 4 (8%) |
| §103 only | 17 (35%) |
| §102 only | 3 (6%) |
| §112 only | 4 (8%) |
| Double-patenting only | 1 (2%) |
| Double-patenting + other | 3 (6%) |
| Multi-statute (no §101) | 16 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ROY, BAISAKHI | 1 | 77.9% | +18.6% |
| BRUTUS, JOEL F | 1 | 72.9% | +17.7% |
| ALI, SHAWKAT M | 1 | 89.2% | +20.5% |
| MATTHEWS, MADISON ROSE | 1 | 80.4% | +34.8% |
| JASANI, ASHISH SHIRISH | 1 | 69.6% | +23.5% |
| FAYE, MAMADOU | 1 | 78.5% | +6.5% |
| ROE, JESSEE RANDALL | 1 | 76.5% | +7.8% |
| WILLSE, DAVID H | 1 | 67.3% | +14.0% |
| GROSS, CHRISTOPHER M | 1 | 63.5% | +40.2% |
| YU, DELPHINUS DOU YI | 1 | 33.3% | +0.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18968893 | TRAUMA GURNEY WITH ENHANCED PATIENT TRANSFER CAPABILITIES | MATTHEWS, MADISON ROSE | 18d overdue |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17625866 | CLOSTRIDIA CONSORTIA COMPOSITIONS AND METHODS OF TREATING OBESITY, METABOLIC SYNDROME AND IRRITABLE BOWEL DISEASE | ESPINOSA, CLAUDIA EDILMA | 60d overdue |
| 17920695 | Implantable Transition Micro-Electrodes | MINCHELLA, ADAM ZACHARY | 45d overdue |
| 17929062 | ASSESSMENT OF MELANOMA THERAPY RESPONSE | GRAY, JESSICA | 44d overdue |
| 18117316 | ELECTRIC GRIP GAUGE FOR ASSESSING HAND DEXTERITY | EISEMAN, ADAM JARED | 8d overdue |
| 17796494 | HIGH MOLECULAR WEIGHT HEPARIN COMPOSITIONS AND METHODS FOR DIAGNOSING, TREATING AND MONITORING EOSINOPHIL MEDIATED INFLAMMATORY DISEASES | MEJIAS, SAMANTHA LEE | 2d overdue |
| 18098538 | THERAPEUTIC DELIVERY DEVICE | VU, QUYNH-NHU HOANG | 33d |
| 19262345 | CARDIAC TISSUE CHARACTERIZATION USING CATHETERIZED LIGHT SCATTERING SPECTROSCOPY | ROY, BAISAKHI | — |
| 18874421 | A WIDE-BAND, MULTI-PHASE PHASE-LOCKED LOOP CIRCUIT | ALI, SHAWKAT M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18968893 | TRAUMA GURNEY WITH ENHANCED PATIENT TRANSFER CAPABILITIES | MATTHEWS, MADISON ROSE | 18d overdue |
| 18869772 | SYSTEM AND METHOD FOR SHARPENING THE FOCAL VOLUME OF THERAPEUTIC AND IMAGING SYSTEMS | JASANI, ASHISH SHIRISH | 34d |
| 19262345 | CARDIAC TISSUE CHARACTERIZATION USING CATHETERIZED LIGHT SCATTERING SPECTROSCOPY | ROY, BAISAKHI | — |
| 19244668 | IMPLANTABLE AND BIODEGRADABLE SMART HYDROGEL MICROMECHANICAL RESONATORS WITH ULTRASOUND READOUT | BRUTUS, JOEL F | — |
| 18874421 | A WIDE-BAND, MULTI-PHASE PHASE-LOCKED LOOP CIRCUIT | ALI, SHAWKAT M | — |
| 18774524 | Variable Transmission For Assistive Prosthesis Device | WILLSE, DAVID H | — |
| 18702311 | PRE-LIBRARY TARGET ENRICHMENT FOR NUCLEIC ACID SEQUENCING | GROSS, CHRISTOPHER M | — |
| Art Unit | Apps |
|---|---|
| 3774 | 3 |
| 3797 | 2 |
| 1684 | 2 |
| 1681 | 2 |
| 1798 | 2 |
| 1642 | 2 |
| 1675 | 2 |
| 1682 | 2 |
| 1654 | 2 |
| 2633 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19262345 | CARDIAC TISSUE CHARACTERIZATION USING CATHETERIZED LIGHT SCATTERING SPECTROSCOPY | ROY, BAISAKHI | 3797 | §103§112 | Non-Final OA | — | Pending | Jul 08, 2025 |
| 19244668 | IMPLANTABLE AND BIODEGRADABLE SMART HYDROGEL MICROMECHANICAL RESONATORS WITH ULTRASOUND READOUT | BRUTUS, JOEL F | 3797 | §103Other | Non-Final OA | — | Pending | Jun 20, 2025 |
| 18874421 | A WIDE-BAND, MULTI-PHASE PHASE-LOCKED LOOP CIRCUIT | ALI, SHAWKAT M | 2633 | §103§112 | Non-Final OA | — | Pending | Dec 12, 2024 |
| 18968893 | TRAUMA GURNEY WITH ENHANCED PATIENT TRANSFER CAPABILITIES | MATTHEWS, MADISON ROSE | 3673 | §103 | Final Rejection | 18d overdue | Pending | Dec 04, 2024 |
| 18869772 | SYSTEM AND METHOD FOR SHARPENING THE FOCAL VOLUME OF THERAPEUTIC AND IMAGING SYSTEMS | JASANI, ASHISH SHIRISH | 3798 | §103 | Final Rejection | 34d | Pending | Nov 26, 2024 |
| 18853061 | UV-BASED, IN-SITU SOIL CARBON MEASUREMENT SYSTEM | FAYE, MAMADOU | 2884 | §103 | Non-Final OA | — | Pending | Sep 30, 2024 |
| 18819806 | Thermo-Hydrogen Refinement of Microstructure of Titanium Materials | ROE, JESSEE RANDALL | 1759 | §103§112Other | Final Rejection | — | Pending | Aug 29, 2024 |
| 18774524 | Variable Transmission For Assistive Prosthesis Device | WILLSE, DAVID H | 3774 | §112 | Non-Final OA | — | Pending | Jul 16, 2024 |
| 18702311 | PRE-LIBRARY TARGET ENRICHMENT FOR NUCLEIC ACID SEQUENCING | GROSS, CHRISTOPHER M | 1684 | §102§103§112 | Non-Final OA | — | Pending | Apr 17, 2024 |
| 18688724 | ADENO-ASSOCIATED VECTORS AND VIRIONS TO TREAT GALACTOSEMIA AND METHODS OF USE AND MANUFACTURE | YU, DELPHINUS DOU YI | 1631 | §102§103§112Other | Non-Final OA | — | Pending | Mar 01, 2024 |
| 18687723 | HYBRIDIZATION PROBES CONTAINING FLUORINATED CARBON CHAINS AND RELATED METHODS | RILEY, JEZIA | 1681 | §102 | Non-Final OA | — | Pending | Feb 28, 2024 |
| 18444305 | COMPOSITIONS AND METHODS OF USE FOR HUMAN RHINOVIRUSES | ALAM, DANYAL HASSAN | 1633 | §101§102§112 | Non-Final OA | — | Pending | Feb 16, 2024 |
| 18407655 | VOLATILE COMPOUND SOURCE LOCATING SYSTEMS | BERA, HENA RAKESHKUMAR | 1798 | §103Other | Final Rejection | — | Pending | Jan 09, 2024 |
| 18573350 | COMPOSITIONS AND METHODS FOR TREATING PGM1 DEFICIENCY | GROOMS, TIFFANY NICOLE | 1637 | §103 | Non-Final OA | — | Pending | Dec 21, 2023 |
| 18537497 | THREE-DIMENSIONAL PERCOLATION ARRAY STRUCTURE AS A GAS SENSOR | HANDY, DWAYNE K | 1798 | §102§103Other | Non-Final OA | — | Pending | Dec 12, 2023 |
| 18527086 | DRUG-ELUTING SUTURE FOR ATTENUATING INFLAMMATION IN WOUNDS | ALAM, AYAAN A | 1611 | §103§112 | Final Rejection | — | Pending | Dec 01, 2023 |
| 18494072 | METHODS FOR FAST NUCLEIC ACID AMPLIFICATION | HORLICK, KENNETH R | 1681 | DP | Final Rejection | 17d overdue | Pending | Oct 25, 2023 |
| 18375485 | CANNULATED CONTINUOUS COMPRESSION SCREW | COLEY, ZADE JAMES | 3775 | §103 | Final Rejection | — | Pending | Sep 30, 2023 |
| 18546258 | TREATMENT OF MYOPIA | HUANG, GIGI GEORGIANA | 1613 | §103DP | Non-Final OA | 21d | Pending | Aug 11, 2023 |
| 18262522 | PNMA2-BASED CAPSIDS AND USES THEREOF | BARRERA, IMMACULADA | 1671 | §103 | Final Rejection | — | Pending | Jul 21, 2023 |
| 18352014 | POLYESTER NETWORKS FROM STRUCTURALLY SIMILAR MONOMERS: RECYCLABLE-BY-DESIGN AND UPCYCLABLE TO PHOTOPOLYMERS | RUNYAN, SILVANA C | 3674 | §103 | Non-Final OA | — | Pending | Jul 13, 2023 |
| 18328456 | Inerter-Based Elastic Metamaterials For Low-Frequency Vibration Mitigation | SAHNI, VISHAL R | 3616 | §103 | Final Rejection | — | Pending | Jun 02, 2023 |
| 18328609 | OCULAR TISSUE SAMPLING DEVICE | GERHARD, ALISON CLAIRE | 1797 | §103 | Non-Final OA | — | Pending | Jun 02, 2023 |
| 18324773 | Zwitterion Polymer-Drug Conjugates | MOSELEY II, NELSON B | 1642 | §102§103 | Non-Final OA | — | Pending | May 26, 2023 |
| 18322420 | COMPOSITE SOLID ELECTROLYTES FOR LITHIUM BATTERIES | MEDLEY, JOHN SAMUEL | 1751 | §102§103§112 | Final Rejection | — | Pending | May 23, 2023 |
| 18196932 | DYNAMIC CELL CULTURE PLATFORM FOR COMBINATORIAL AND BIOMECHANICAL STIMULATION | CARREON, ADRIAN JOHN | 1799 | §102§103 | Final Rejection | — | Pending | May 12, 2023 |
| 18315999 | HIGH-EFFICIENCY ELECTROLYSIS OF IRON ORE FOR IRON PRODUCTION | MENDEZ, ZULMARIAM | 1794 | §102§103 | Final Rejection | — | Pending | May 11, 2023 |
| 18033052 | Volitional Walking Controller | HU, ANN M | 3774 | §102 | Non-Final OA | — | Pending | Apr 20, 2023 |
| 18032790 | Powered Joint System with Enhanced Neural-Based Controller | PATEL, AREN | 3774 | §102§103 | Non-Final OA | — | Pending | Apr 19, 2023 |
| 18117316 | ELECTRIC GRIP GAUGE FOR ASSESSING HAND DEXTERITY | EISEMAN, ADAM JARED | 3791 | §102§103 | Non-Final OA | 8d overdue | Pending | Mar 03, 2023 |
| 18043792 | SYSTEMS AND METHODS FOR CONTROLLING BACTERIAL TRANSCRIPTION | REGA, KYLE THOMAS | 1636 | §103 | Final Rejection | 5d overdue | Pending | Mar 02, 2023 |
| 18173680 | Compositions and Methods for Killing PD-1 Positive Cells | BERHANE, SELAM | 1675 | §112 | Final Rejection | 40d | Pending | Feb 23, 2023 |
| 18098538 | THERAPEUTIC DELIVERY DEVICE | VU, QUYNH-NHU HOANG | 3783 | §102§103 | Non-Final OA | 33d | Pending | Jan 18, 2023 |
| 18010580 | BIOMARKER BASED PATIENT SELECTION FOR PROTEASOME INHIBITOR TREATMENT | AEDER, SEAN E | 1642 | §102 | Non-Final OA | — | Pending | Dec 15, 2022 |
| 17920695 | Implantable Transition Micro-Electrodes | MINCHELLA, ADAM ZACHARY | 3794 | §102§103 | Final Rejection | 45d overdue | Pending | Oct 21, 2022 |
| 17963119 | MULTI-SEQUENCE CAPTURE SYSTEM | ZHANG, KAIJIANG | 1684 | §112 | Non-Final OA | — | Pending | Oct 10, 2022 |
| 17929062 | ASSESSMENT OF MELANOMA THERAPY RESPONSE | GRAY, JESSICA | 1682 | §101§103§112 | Final Rejection | 44d overdue | Pending | Sep 01, 2022 |
| 17900240 | IMPLANTABLE BONE SCAFFOLDS INCLUDING AT LEAST ONE INTEGRATION AID, METHODS OF MAKING AND USING THE SAME | LIU, TRACY | 1614 | §103DP | Non-Final OA | 35d overdue | Pending | Aug 31, 2022 |
| 17796494 | HIGH MOLECULAR WEIGHT HEPARIN COMPOSITIONS AND METHODS FOR DIAGNOSING, TREATING AND MONITORING EOSINOPHIL MEDIATED INFLAMMATORY DISEASES | MEJIAS, SAMANTHA LEE | 1618 | §101§103§112 | Non-Final OA | 2d overdue | Pending | Jul 29, 2022 |
| 17776563 | OPTIDICER CONSTRUCT FOR AGE-RELATED MACULAR DEGENERATION | MONTANARI, DAVID A | 1632 | §112 | Final Rejection | 66d overdue | Pending | May 12, 2022 |
| 17724296 | METHODS AND SYSTEMS FOR MULTIPLE TAXONOMIC CLASSIFICATION | WOITACH, JOSEPH T | 1687 | §101§103Other | Non-Final OA | — | Pending | Apr 19, 2022 |
| 17766489 | TARGETED SEQUENCING TO DETECT AND QUANTIFY LOW LEVELS OF METHYLATED DNA | DAUNER, JOSEPH G | 1682 | §103 | Final Rejection | — | Pending | Apr 04, 2022 |
| 17760668 | Conformationally-Constrained Alpha-RGIA Analogues | STEELE, AMBER D | 1658 | §102§103Other | Final Rejection | — | Pending | Mar 15, 2022 |
| 17640627 | COMPOSITIONS AND METHODS FOR USING SILK-ELASTINLIKE PROTEIN-BASED POLYMERS | FONTAINHAS, AURORA M | 1675 | §103 | Final Rejection | 113d overdue | Pending | Mar 04, 2022 |
| 17626469 | MULTI-AGENT OCULAR FORMULATIONS AND TREATMENT METHODS | PIPIC, ALMA | 1617 | §103Other | Final Rejection | — | Pending | Jan 11, 2022 |
| 17625866 | CLOSTRIDIA CONSORTIA COMPOSITIONS AND METHODS OF TREATING OBESITY, METABOLIC SYNDROME AND IRRITABLE BOWEL DISEASE | ESPINOSA, CLAUDIA EDILMA | 1654 | §101 | Final Rejection | 60d overdue | Pending | Jan 10, 2022 |
| 17616111 | NOVEL LIVE-CELL ASSAY FOR NEURONAL ACTIVITY | NICOL, ALEXANDER W | 1634 | §103 | Non-Final OA | 2d overdue | Pending | Dec 02, 2021 |
| 17528853 | MICRO-MOLDED ELECTRODES, ARRAYS, AND METHODS OF MAKING THE SAME | CAZAN, LIVIUS RADU | 3729 | §103 | Non-Final OA | — | Pending | Nov 17, 2021 |
| 17348694 | DIMERIC COLLAGEN HYBRIDIZING PEPTIDES AND METHODS OF USE THEREOF | SABILA, MERCY HELLEN | 1654 | §102§112DP | Non-Final OA | — | Pending | Jun 15, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUniversity of Utah Research Foundation has 49 pending office actions as of October 2026, spread across 39 art units and 49 examiners.
Baisakhi Roy has the most, with 1 of University of Utah Research Foundation's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
